Go Pro

KORU Medical Systems (KRMD) Competitors

KORU Medical Systems logo
$3.23 +0.01 (+0.31%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$3.13 -0.10 (-3.07%)
As of 09/18/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KRMD vs. DCTH, BWAY, TCMD, NPCE, and SGHT

Should you buy KORU Medical Systems stock or one of its competitors? KORU Medical Systems's main competitors and comparable companies include Delcath Systems (DCTH), Brainsway (BWAY), Tactile Systems Technology (TCMD), NeuroPace (NPCE), and Sight Sciences (SGHT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does KORU Medical Systems compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Delcath Systems has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Delcath Systems$85.23M6.56$2.70M$0.011,611.00
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A

Delcath Systems has a net margin of 0.56% compared to KORU Medical Systems' net margin of -4.03%. Delcath Systems' return on equity of 0.46% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Delcath Systems0.56% 0.46% 0.42%
KORU Medical Systems -4.03%-10.63%-6.51%

Delcath Systems has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its share price is 57% less volatile than the broader market.

Delcath Systems currently has a consensus price target of $23.17, suggesting a potential upside of 43.80%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Delcath Systems
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.86
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, Delcath Systems and Delcath Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Delcath Systems' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Delcath Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Delcath Systems beats KORU Medical Systems on 14 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

KORU Medical Systems (NASDAQ:KRMD) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.34 beat Brainsway's score of 0.88 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Brainsway
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
Brainsway$52.22M10.48$7.57M$0.4430.93

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 116.72%. Brainsway has a consensus target price of $18.20, indicating a potential upside of 33.73%. Given KORU Medical Systems' higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Brainsway
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Brainsway has a net margin of 15.65% compared to KORU Medical Systems' net margin of -4.03%. Brainsway's return on equity of 12.74% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
Brainsway 15.65%12.74%8.17%

Summary

Brainsway beats KORU Medical Systems on 12 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

KORU Medical Systems (NASDAQ:KRMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

Tactile Systems Technology has a net margin of 7.10% compared to KORU Medical Systems' net margin of -4.03%. Tactile Systems Technology's return on equity of 11.49% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
Tactile Systems Technology 7.10%11.49%9.17%

In the previous week, KORU Medical Systems had 1 more articles in the media than Tactile Systems Technology. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for Tactile Systems Technology. KORU Medical Systems' average media sentiment score of 1.34 beat Tactile Systems Technology's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Overall Sentiment
KORU Medical Systems Positive
Tactile Systems Technology Neutral

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
Tactile Systems Technology$329.52M1.53$19.09M$1.0820.56

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

KORU Medical Systems presently has a consensus price target of $7.00, indicating a potential upside of 116.72%. Tactile Systems Technology has a consensus price target of $38.40, indicating a potential upside of 72.97%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Tactile Systems Technology
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Tactile Systems Technology beats KORU Medical Systems on 10 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to NeuroPace?

KORU Medical Systems (NASDAQ:KRMD) and NeuroPace (NASDAQ:NPCE) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 116.72%. NeuroPace has a consensus target price of $19.33, indicating a potential upside of 35.39%. Given KORU Medical Systems' higher possible upside, equities analysts plainly believe KORU Medical Systems is more favorable than NeuroPace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
NeuroPace
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.90

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, NeuroPace has a beta of 1.94, suggesting that its stock price is 94% more volatile than the broader market.

In the previous week, NeuroPace had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat NeuroPace's score of 0.47 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeuroPace
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems has higher earnings, but lower revenue than NeuroPace. KORU Medical Systems is trading at a lower price-to-earnings ratio than NeuroPace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A
NeuroPace$99.99M4.90-$21.47M-$0.57N/A

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 78.8% of NeuroPace shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 19.2% of NeuroPace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

KORU Medical Systems has a net margin of -4.03% compared to NeuroPace's net margin of -19.34%. KORU Medical Systems' return on equity of -10.63% beat NeuroPace's return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-4.03% -10.63% -6.51%
NeuroPace -19.34%-105.64%-16.51%

Summary

NeuroPace beats KORU Medical Systems on 10 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Sight Sciences presently has a consensus price target of $7.88, suggesting a potential downside of 1.81%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 116.72%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Sight Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 30.4% of Sight Sciences shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

KORU Medical Systems has a net margin of -4.03% compared to Sight Sciences' net margin of -35.69%. KORU Medical Systems' return on equity of -10.63% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-35.69% -43.39% -22.86%
KORU Medical Systems -4.03%-10.63%-6.51%

In the previous week, Sight Sciences had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Sight Sciences and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.34 beat Sight Sciences' score of 0.26 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sight Sciences
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

KORU Medical Systems has lower revenue, but higher earnings than Sight Sciences. KORU Medical Systems is trading at a lower price-to-earnings ratio than Sight Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$77.36M5.71-$38.43M-$0.56N/A
KORU Medical Systems$41.13M3.61-$2.64M-$0.04N/A

Sight Sciences has a beta of 2.5, indicating that its stock price is 150% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

Summary

KORU Medical Systems beats Sight Sciences on 9 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRMD vs. The Competition

MetricKORU Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$148.36M$5.55B$7.24B$13.19B
Dividend YieldN/A1.80%2.57%12.81%
P/E Ratio-80.7525.34275.4925.40
Price / Sales3.6172.49646.0189.45
Price / CashN/A32.6476.2551.42
Price / Book8.735.6910.466.33
Net Income-$2.64M$151.55M$3.49B$358.33M
7 Day Performance2.22%0.66%0.59%1.12%
1 Month Performance-1.22%-3.33%-1.74%-2.39%
1 Year Performance-22.36%6.79%18.13%5.35%

KORU Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRMD
KORU Medical Systems
3.6914 of 5 stars
$3.23
+0.3%
$7.00
+116.7%
-22.4%$148.36M$41.13MN/A73
DCTH
Delcath Systems
2.783 of 5 stars
$16.17
-1.6%
$23.17
+43.3%
+39.6%$570.45M$85.23M1,618.62156
BWAY
Brainsway
4.6423 of 5 stars
$13.46
-1.2%
$18.20
+35.2%
+76.0%$548.03M$52.22M30.59129
TCMD
Tactile Systems Technology
3.3292 of 5 stars
$22.51
-0.3%
$38.40
+70.6%
+57.9%$511.26M$329.52M20.841,086
NPCE
NeuroPace
3.2186 of 5 stars
$14.25
-2.3%
$19.50
+36.8%
+43.7%$500.79M$99.99MN/A220

Related Companies and Tools


This page (NASDAQ:KRMD) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners